FEB 19, 2014 9:00 AM PST

Next-generation RNA-Seq and Exome-Seq using Ion Proton Sequencer for translational oncology research

Speaker
  • Assistant Professor Department of Surgery, Division of General Surgery, Indiana University School of Medicine Indiana University Melvin and Bren Simon Cancer Center IU Center for Computationa

Abstract
Genome sequencing technologies have enabled a rapid expansion into understanding cancer biology, drug development, and treatment resistance. Research in our laboratory has focused on the application of Ion Proton sequencing of breast cancer tumors and other rare tumors. This presentation will detail how we have harnessed Ion Proton Sequencers for RNA-Seq (transcriptome sequencing) and exome sequencing on tumor tissues to reveal possible drug targets and implement rational drug combinations. Further, work on how Ion Proton sequencing is being used for biomarker discovery in retrospective cancer clinical research studies to enable insights into cancer biology and pharmacogenomics will also be presented.

Show Resources
You May Also Like
JAN 23, 2020 9:00 AM PST
C.E. CREDITS
JAN 23, 2020 9:00 AM PST
DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
APR 07, 2020 8:00 AM PDT
C.E. CREDITS
APR 07, 2020 8:00 AM PDT
DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
FEB 26, 2020 9:00 AM PST
C.E. CREDITS
FEB 26, 2020 9:00 AM PST
DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
MAY 08, 2020 10:00 AM PDT
C.E. CREDITS
MAY 08, 2020 10:00 AM PDT
DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
MAR 31, 2020 9:00 AM PDT
C.E. CREDITS
MAR 31, 2020 9:00 AM PDT
DATE: March 31, 2020 TIME: 9:00am PT, 12:00pm ET HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2...
JUN 23, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
JUN 23, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
Loading Comments...
Show Resources
Attendees
  • See more